Posted by
Repetitive TMS Effective for Comorbid Major Depressive Disorder, Anxiety

Repetitive TMS Effective for Comorbid Major Depressive Disorder, Anxiety

Repetitive transcranial magnetic stimulation (rTMS) showed efficacy in patients with major depressive disorder (MDD) and comorbid anxiety, according to results from a study published in the Journal of Affective Disorders. Researchers conducted a single-site, nonrandomized, comparison study of 248 patients who received rTMS therapy for treatment-resistant MDD. Among those included, 172 participants had a minimum of 1 comorbid […]

Posted by
Celebrating a Beautiful Life One Brush Stroke at a Time.

Celebrating a Beautiful Life One Brush Stroke at a Time.

The colorful painting of a bass player that hangs in the office of Robert Pollack, MD, is typical of Cori Scheft’s work. It’s a vivid and vibrant collage of brightly dyed newspaper clippings, fabrics and strips of sheet music that believe one simple fact: Cori has been suffering from a Brain Disease know as Depression. […]

Posted by
High-frequency Brain Stimulation Is Superior for Parkinson’s Patients, Study Suggests

High-frequency Brain Stimulation Is Superior for Parkinson’s Patients, Study Suggests

Repetitive transcranial magnetic stimulation (rTMS), given at high or low frequency, effectively reduces motor symptoms in Parkinson’s disease patients, but the effects of high-frequency rTMS are superior and last longer, a clinical trial shows. Investigators also found that the treatment is more effective in patients with akinetic-rigid Parkinson’s — those with slow movements and rigidity — than in patients with […]

Posted by
VA to offer new ketamine-based nasal spray to help combat depression

VA to offer new ketamine-based nasal spray to help combat depression

Editor’s Note: This article by Patricia Kime originally appeared on Military.com, a leading source of news for the military and veteran community. The newest FDA-approved medication to treat severe depression, a nasal spray based on the anesthetic (and misused hallucinogenic party drug) ketamine, will soon be available to veterans treated within the Department of Veterans Affairs. In a […]

Posted by
Treatment-Naive Women Commonly Over-prescribed Zolpidem

Treatment-Naive Women Commonly Over-prescribed Zolpidem

The use of higher-than-recommended doses of zolpidem was commonly seen in women not previously treated with the drug, according to results from a study published in the Journal of Clinical Psychiatry. Researchers conducted a retrospective cohort study of 139,525 people who had never been treated with zolpidem and were prescribed the drug from January 1, 2013, […]

Posted by
Mild Depression Predictive of All-Cause Mortality After MI

Mild Depression Predictive of All-Cause Mortality After MI

Mild depression was a long-term independent predictor of death in patients after acute myocardial infarction (AMI), per cohort study data published in Heart, Lung and Circulation. Investigators conducted a 25-year follow-up of men who were recruited after AMI to participate in a randomized controlled trial in the 1980s. The initial trial investigated the impact of high intensity exercise […]

Posted by
The Psychopharmacology of Depression: Strategies, Formulations, and Future Implications

The Psychopharmacology of Depression: Strategies, Formulations, and Future Implications

With well over two dozen traditional antidepressants available in the US, and an ever-growing list of other psychotropic compounds with apparent antidepressant properties, pharmacological options for treating clinical depression today are broad and vast. However, recent findings suggest that the magnitude of efficacy for most antidepressants compared with placebo may be more modest than previously […]

Posted by
Robert Pollack, MD Certified in Spravato REMS

Robert Pollack, MD Certified in Spravato REMS

Robert Pollack, MD has been certified in the Restrictive Program called Spravato REMS (Risk Evaluation and Mitigation Strategy) for the administration and monitoring of Spravato, the newly released Intranasal formulation of Esketamine for the treatment of TRD (Treatment Resistant Depression). Janssen announced that they received FDA approval for this medication February 5 , 2019. For […]

Posted by
In scathing ruling, judge rips insurer for putting ‘bottom line’ over patients’ health

In scathing ruling, judge rips insurer for putting ‘bottom line’ over patients’ health

In a scathing decision, a federal judge blasted a subsidiary of the nation’s largest insurance company for focusing on the “bottom line as much or more” than patients’ health, saying the insurer illegally denied treatment to thousands of people. The judge also slammed the company’s medical directors for being “deceptive” under oath.US Chief Magistrate Judge […]